Cyprus/Greece/MaltaCyprusGreeceMalta

Golgi Pharmaceuticals expands marketing

16.04.2009

Golgi Pharmaceuticals of Cyprus is strengthening its collaboration with London-based ReGen Therapeutics. Golgi will produce tablets of and package Colostrinin, and expand distribution to Greece and other Balcan countries. Colostrinin is a proline-rich polypeptide complex derived from mammalian colostrum. The complex and peptides within it could have a potential use in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral Sclerosis according to clinical studies conducted in Poland in the year 2002.
To date, Colostrinin is marketed in the US, Canada and Australia under the brand name CogniSure and in Cyprus under the brand name Cognase as a nutritional supplement to support healthy brain aging and cognition in humans. It is currently being test marketed in Poland under the brand name CogniSure prior to a full launch in that country. Golgi Pharmaceuticals is based in Nicosia, Cyprus, and specialises in the national distribution of pharmaceuticals and nutraceuticals. Cyprus was the first EU state, in which Colostrinin became available in 2008.

Cyprus/Greece/MaltaCyprusGreeceMalta

06.03.2005

Athens - A three-day conference covering all issues of biotechnology at both fundamental and application level will be held in July this year in Athens: “2nd International Greek Biotechnology Forum - IGBF2”. The event aims at...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2005

Athens - The Greek agriculture minister recently announced that the country will destroy over 9,000 acres of fields planted with biotech-mixed cotton. The Greek government will pay affected farmers an estimated Euro4 million....

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2005

Heraklion/Paris - Together with French Vaxon-Biotech S.A. the Herak-lion University Hospital in Crete has completed the phase I trial of Vaxon's candidate vaccine VX-001, which contains a single optimized cryptic peptide that...

Cyprus/Greece/MaltaCyprusGreeceMalta

13.11.2004

Athens - The Hellenic Innovation Centre presented a new technology in October that enables the production of high-grade pharmaceutical raw material like Inter-feron- and - , Erythropoietin, FSH, and HGH, without unwanted...

Cyprus/Greece/MaltaCyprusGreeceMalta

09.10.2004

Heraklion - The recent research advances on lymphocytes, the most sophisticated of all mature hematopoietic cell types, will be presented during the 2nd Gene Regulation in Lymphocyte Develop-ment Workshop to be held on October...

Cyprus/Greece/MaltaCyprusGreeceMalta

08.05.2004

Valetta - Further to the launch of its DNA Forensics division in February 2004, Synergene Profiling, a subsidiary of the Synergene Biotechnology Group, has successfully completed its first DNA forensic cases.Contracted on behalf...

Cyprus/Greece/MaltaCyprusGreeceMalta

08.05.2004

Athens - The Helenic Society for the Study and Applications of Growth Hormones will hold the 2nd International Congress on Adult Consequences of Childhood Endocrine Diseases from May 6-8 in Athens. Main topics are going to be the...

Cyprus/Greece/MaltaCyprusGreeceMalta

09.04.2004

Attard - The international network Gendia has recently developed a new fast pre-natal test for the most common aneuploidies by quantitative fluorescent PCR (QF-PCR). Gendia was founded last year by the Malta-based biotech company...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.03.2004

Rhodos - SEED ECOLOGY 2004, the first thematic, scientific conference devoted exclusively to seeds and the environment, will take place in Rhodos (April 25 to May 1). The scientific program will cover all aspects of seed eco-logy...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2004

Athens - Biovista recently announced he licensing of its Journal Research AnalystTM (JRA) market intelligence tool by Upstate, Chalottesville/USA, one of the leading suppliers of cell signaling reagents and kinase screening...

Displaying results 31 to 40 out of 47

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-cyprus-greece-malta/browse/3/article/golgi-pharmaceuticals-expands-marketing.html

Events

All Events

Stock list

All quotes

TOP

  • ADDEX3.30 CHF6.45%
  • PAION3.17 EUR3.93%
  • SANTHERA90.75 CHF3.07%

FLOP

  • WILEX2.36 EUR-12.27%
  • THERAMETRICS0.08 CHF-11.11%
  • CYTOS0.23 CHF-4.17%

TOP

  • CO.DON3.27 EUR30.8%
  • PAION3.17 EUR27.8%
  • EPIGENOMICS3.80 EUR22.6%

FLOP

  • MEDIGENE3.82 EUR-17.8%
  • ADDEX3.30 CHF-17.5%
  • EVOTEC3.10 EUR-15.5%

TOP

  • SANTHERA90.75 CHF2124.3%
  • CO.DON3.27 EUR280.2%
  • PAION3.17 EUR213.9%

FLOP

  • CYTOS0.23 CHF-94.3%
  • THERAMETRICS0.08 CHF-42.9%
  • BIOFRONTERA2.18 EUR-40.3%

No liability assumed, Date: 21.09.2014


Current issue

All issues

Product of the week

Products